Negi S - Search Results

1

Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial).

Negi S, Shukrullah I, Veledar E, Bloom HL, Jones DP, Dudley SC. Negi S, et al. J Cardiovasc Electrophysiol. 2011 Apr;22(4):414-9. doi: 10.1111/j.1540-8167.2010.01925.x. Epub 2010 Oct 13. J Cardiovasc Electrophysiol. 2011. PMID: 20946227 Free PMC article. Clinical Trial.

2

Atrial fibrillation: the emerging role of inflammation and oxidative stress.

Negi S, Sovari AA, Dudley SC Jr. Negi S, et al. Cardiovasc Hematol Disord Drug Targets. 2010 Dec 1;10(4):262-8. doi: 10.2174/187152910793743850. Cardiovasc Hematol Disord Drug Targets. 2010. PMID: 20932266 Review.

3

A Circulating Biomarker Risk-Prediction Model Correlates with CHADS-2 Risk Score in Chronic Atrial Fibrillation.

Negi SI, Greener I, Anand A, Dudley SC Jr. Negi SI, et al. IJC Metab Endocr. 2015 Mar;6:24-26. doi: 10.1016/j.ijcme.2015.01.002. IJC Metab Endocr. 2015. PMID: 25709897 Free PMC article.

4

Renin-Angiotensin Activation and Oxidative Stress in Early Heart Failure with Preserved Ejection Fraction.

Negi SI, Jeong EM, Shukrullah I, Veleder E, Jones DP, Fan TH, Varadarajan S, Danilov SM, Fukai T, Dudley SC Jr. Negi SI, et al. Biomed Res Int. 2015;2015:825027. doi: 10.1155/2015/825027. Epub 2015 Oct 4. Biomed Res Int. 2015. PMID: 26504834 Free PMC article.

5

Association of low plasma adiponectin with early diastolic dysfunction.

Negi SI, Jeong EM, Shukrullah I, Raicu M, Dudley SC Jr. Negi SI, et al. Congest Heart Fail. 2012 Jul-Aug;18(4):187-91. doi: 10.1111/j.1751-7133.2011.00276.x. Epub 2012 Jan 9. Congest Heart Fail. 2012. PMID: 22809257 Free PMC article.

6

Enhanced risk profiling of implanted defibrillator shocks with circulating SCN5A mRNA splicing variants: a pilot trial.

Gao G, Brahmanandam V, Raicu M, Gu L, Zhou L, Kasturirangan S, Shah A, Negi SI, Wood MR, Desai AA, Tatooles A, Schwartz A, Dudley SC Jr. Gao G, et al. Among authors: negi si. J Am Coll Cardiol. 2014 Jun 3;63(21):2261-9. doi: 10.1016/j.jacc.2014.02.588. Epub 2014 Apr 2. J Am Coll Cardiol. 2014. PMID: 24703920 Free PMC article. Clinical Trial.

7

Atherosclerotic coronary heart disease-epidemiology, classification and management.

Negi S, Anand A. Negi S, et al. Cardiovasc Hematol Disord Drug Targets. 2010 Dec 1;10(4):257-61. doi: 10.2174/187152910793743832. Cardiovasc Hematol Disord Drug Targets. 2010. PMID: 20932265 Review.

8

Statin Adherence and Poverty - The Wide Gap in Cardiovascular Prevention.

Negi SI, Duggal B, Kant R. Negi SI, et al. Cardiovasc Revasc Med. 2020 Aug;21(8):1022-1023. doi: 10.1016/j.carrev.2020.06.012. Epub 2020 Jun 10. Cardiovasc Revasc Med. 2020. PMID: 32563710 No abstract available.

9

A single center experience of Zilver PTX for femoro-popliteal lesions.

Kang WY, Campia U, Didier RJ, Kiramijyan S, Koifman E, Negi SI, Lipinski MJ, Baker NC, Escarcega RO, Torguson R, Waksman R, Bernardo NL. Kang WY, et al. Among authors: negi si. Cardiovasc Revasc Med. 2016 Sep;17(6):399-403. doi: 10.1016/j.carrev.2016.02.004. Epub 2016 Feb 9. Cardiovasc Revasc Med. 2016. PMID: 27496591

10

Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement.

Kiramijyan S, Koifman E, Asch FM, Magalhaes MA, Didier R, Escarcega RO, Negi SI, Baker NC, Jerusalem ZD, Gai J, Torguson R, Okubagzi P, Wang Z, Shults CC, Ben-Dor I, Corso PJ, Satler LF, Pichard AD, Waksman R. Kiramijyan S, et al. Among authors: negi si. Am J Cardiol. 2016 Mar 1;117(5):839-46. doi: 10.1016/j.amjcard.2015.11.064. Epub 2015 Dec 13. Am J Cardiol. 2016. PMID: 26873331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

641 results

Search Page